Social determinants of health, such as Area Deprivation Index scores, may be considered mild cognitive impairment risk factors among older adults.

Explore the potential of monoclonal antibodies in Alzheimer’s treatment, including breakthroughs and challenges in this ...

Though antioxidants are good for your health, taking them in supplement form is often unnecessary and can pose risks. Here's ...

The U.S. Food and Drug Administration (FDA) has approved monthly maintenance dosing for Leqembi (lecanemab), a treatment for early Alzheimer’s disease.

II-73, has the potential to restore memory and cognitive function in a mouse model of Alzheimer's disease. The study demonstrates that the drug improves memory deficits and reverses brain cell damage, ...

Impairment Science specializes in cognitive impairment technologies, providing solutions, including DRUID, its fit-for-duty app, that enhance workplace safety and productivity. Our innovative approach ...

Scientists have pinpointed a brain circuit that, when activated, reduces anxiety without impairing memory. Using ...

A paradigm-shifting study from the Centre for Addiction and Mental Health (CAMH) shows an experimental drug, GL-II-73, has the potential to restore memory and cognitive function in a mouse model of ...

Verywell Health's content is for informational and educational purposes only. Our website is not intended to be a substitute ...

Most people with dementia in the US are unaware of their condition. A population-based study in Texas has now found that four ...

After adjusting for other dementia risk factors such as age, smoking status, and high blood pressure, researchers found that ...

Could changes in cholesterol be a warning sign of dementia? A new study suggests that older adults whose cholesterol ...